Daiwa Securities Group Inc. Has $2.08 Million Holdings in Teleflex Incorporated (NYSE:TFX)

Daiwa Securities Group Inc. boosted its position in Teleflex Incorporated (NYSE:TFX) by 3.4% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 11,674 shares of the medical technology company’s stock after purchasing an additional 379 shares during the period. Daiwa Securities Group Inc.’s holdings in Teleflex were worth $2,077,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the company. Apollon Wealth Management LLC grew its position in Teleflex by 3.7% in the 3rd quarter. Apollon Wealth Management LLC now owns 1,524 shares of the medical technology company’s stock worth $377,000 after purchasing an additional 55 shares in the last quarter. SRS Capital Advisors Inc. grew its position in Teleflex by 0.3% in the 3rd quarter. SRS Capital Advisors Inc. now owns 19,587 shares of the medical technology company’s stock worth $4,844,000 after purchasing an additional 60 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. grew its position in Teleflex by 4.5% in the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 1,517 shares of the medical technology company’s stock worth $375,000 after purchasing an additional 66 shares in the last quarter. HighTower Advisors LLC grew its position in Teleflex by 1.7% in the 3rd quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company’s stock worth $986,000 after purchasing an additional 66 shares in the last quarter. Finally, Huntington National Bank grew its position in Teleflex by 32.5% in the 3rd quarter. Huntington National Bank now owns 310 shares of the medical technology company’s stock worth $77,000 after purchasing an additional 76 shares in the last quarter. 95.62% of the stock is owned by institutional investors.

Teleflex Stock Up 1.1 %

TFX opened at $137.79 on Friday. The company has a 50 day moving average of $166.99 and a 200 day moving average of $197.99. The company has a market cap of $6.39 billion, a PE ratio of 27.39, a price-to-earnings-growth ratio of 1.73 and a beta of 1.21. Teleflex Incorporated has a 12 month low of $128.55 and a 12 month high of $249.90. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, topping the consensus estimate of $3.86 by $0.03. The company had revenue of $795.40 million during the quarter, compared to the consensus estimate of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. On average, sell-side analysts expect that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Friday, March 7th will be paid a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 0.99%. The ex-dividend date is Friday, March 7th. Teleflex’s dividend payout ratio is presently 95.77%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. Piper Sandler reaffirmed a “neutral” rating and issued a $140.00 price objective (down from $255.00) on shares of Teleflex in a research report on Friday, February 28th. StockNews.com downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a research report on Friday, February 28th. Royal Bank of Canada downgraded shares of Teleflex from an “outperform” rating to a “sector perform” rating and reduced their target price for the company from $220.00 to $155.00 in a research report on Friday, February 28th. Wells Fargo & Company reduced their target price on shares of Teleflex from $214.00 to $146.00 and set an “equal weight” rating for the company in a research report on Friday, February 28th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research report on Wednesday. One analyst has rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $182.63.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.